olivLaw · European equity research
Faes Farma SA FAE.MC
Spain · BME Madrid · ISIN ES0134950F36 · Vertical: Listed companies from Spain
At the close of 05 Nov 2026, Faes Farma SA (FAE.MC) stock was 4.91 EUR (+0.31% on the day), with market capitalisation 1.5 bn EUR, P/E 19.3 on diluted EPS of 0.25 EUR over the last 12 months, dividend yield 3.65%, beta 0.46, 52-week range 4.35–5.38 EUR.
Data as of · Source: ESEF annual reports and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 61.0
- strong (55–70)
- Bollinger (20, 2)
- 4.63 – 4.97
- in the upper half of the band · %B 0.82 · band width 7.2%
- SMA 50 / 200
- 4.67 / 4.71
- mixed trend
- MACD (12, 26, 9)
- 0.05 / 0.04
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | EURO STOXX 50 | vs EURO STOXX 50 | Vertical median | |
|---|---|---|---|---|
| 1 month | +3.4% | +0.4% | +3.0 pp | — |
| 3 months | +8.3% | −3.3% | +11.5 pp | — |
| 6 months | +0.1% | +4.0% | −3.9 pp | — |
| Year to date | −4.8% | +8.1% | −12.9 pp | — |
| 1 year | +12.0% | +10.7% | +1.3 pp | +6.7% |
| 3 years | +63.1% | +50.1% | +13.0 pp | +26.0% |
| 5 years | +44.8% | +43.6% | +1.2 pp | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 67 percentile of its own 3-quarter history (min 9.8, median 10.7, max 20.3; quarters with earnings only).
Fiscal years
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 451.2 m | 493.6 m | 610.5 m |
| Revenue YoY | unavailable | +9.4% | +23.7% |
| Net income | 91.9 m | 111.4 m | 79.6 m |
| Net income YoY | unavailable | +21.2% | −28.5% |
| Diluted EPS | 0.30 | 0.36 | 0.25 |
| Diluted EPS YoY | unavailable | +20.3% | −28.7% |
| net % | 20.4% | 22.6% | 13.0% |
| Free cash flow | 5.2 m | 81.7 m | 62.4 m |
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 117.3 m EUR
- Financial debt
- unavailable EUR
- Net debt
- unavailable EUR
- Equity
- 745.6 m EUR
- Total assets
- 1.3 bn EUR
- Debt / equity
- unavailable
- Current ratio
- 2.61x
- ROE
- 10.8%
- ROA
- 7.3%
- FCF margin
- 10.2%
Financial statements (source on every figure)
Revenue and net income (EUR)
Margins
Income statement · EUR
| Line | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|
| Revenue | 451.2 m | 493.6 m | 610.5 m | esef· 20 Oct 2026verified |
| Depreciation & amortisation | 19.4 m | 20.3 m | 29.0 m | esef· 20 Oct 2026verified |
| Interest expense | 1.0 m | 1.2 m | 6.1 m | esef· 20 Oct 2026verified |
| Pre-tax income | 102.9 m | 107.6 m | 85.4 m | esef· 20 Oct 2026verified |
| Income tax | 11.2 m | -3.5 m | 5.8 m | esef· 20 Oct 2026verified |
| Net income | 91.9 m | 111.4 m | 79.6 m | esef· 20 Oct 2026verified |
| Diluted EPS | 0.30 | 0.36 | 0.25 | esef· 20 Oct 2026verified |
| Dividend per share | 0.05 | 0.16 | 0.18 | esef· 20 Oct 2026derived |
Balance sheet · EUR
| Line | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|
| Cash | 34.6 m | 64.2 m | 117.3 m | esef· 20 Oct 2026verified |
| Receivables | 113.5 m | 119.1 m | 167.3 m | esef· 20 Oct 2026verified |
| Inventories | 129.0 m | 142.5 m | 185.0 m | esef· 20 Oct 2026verified |
| Current assets | 290.3 m | 333.7 m | 482.4 m | esef· 20 Oct 2026verified |
| Property, plant & equipment, net | 274.1 m | 295.4 m | 343.0 m | esef· 20 Oct 2026verified |
| Total assets | 776.6 m | 853.1 m | 1.3 bn | esef· 20 Oct 2026verified |
| Accounts payable | 56.0 m | 71.3 m | 121.4 m | esef· 20 Oct 2026verified |
| Current liabilities | 87.3 m | 103.5 m | 184.9 m | esef· 20 Oct 2026verified |
| Total liabilities | 113.2 m | 126.5 m | 596.3 m | esef· 20 Oct 2026verified |
| Equity | 663.4 m | 726.6 m | 745.6 m | esef· 20 Oct 2026verified |
| Shares outstanding at year end | 310.5 m | 311.1 m | 311.1 m | esef· 20 Oct 2026derived |
Cash flow · EUR
| Line | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|
| Operating cash flow | 101.0 m | 115.5 m | 78.5 m | esef· 20 Oct 2026verified |
| Capex | 95.8 m | 33.8 m | 16.1 m | esef· 20 Oct 2026verified |
| Free cash flow | 5.2 m ≈ | 81.7 m ≈ | 62.4 m ≈ | esef· 20 Oct 2026derived |
| Investing cash flow | -97.4 m | -34.2 m | -299.0 m | esef· 20 Oct 2026verified |
| Financing cash flow | -35.4 m | -51.7 m | 273.6 m | esef· 20 Oct 2026verified |
| Dividends paid | 14.6 m | 48.2 m | 55.7 m | esef· 20 Oct 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- score weight coverage: 45.8% of at least 60%
A scoring methodology on indicators and valuation, not investment advice.
Closing price
05 Nov 2026Source: olivLaw, closing series
Market cap: 1.5 bn EUR
Key indicators
Coverage and freshness
Score by group
46% · Insufficient data
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 2.44 – 5.77 EUR.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (EUR per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)unavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: P/E3.86 – 5.77 (Mid 5.14)18 companies used · median multiple 20.3x · quartiles 15.2x – 22.7xACS.MC, ADX.MC, AEDAS.MC, AENA.MC, AMS.MC, ANA.MC, CAF.MC, CLEO.MC, CMO.MC, DESA.MC, DIA.MC, EAT.MC, EDR.MC, ELE.MC, ENER.MC, ENO.MC, FCC.MC, FDR.MC
- Dividend discount (DDM)2.44 – 3.32 (Mid 2.81)
Assumptions (illustrative, editorial)
- Risk-free rate
- 3.0%
- Equity risk premium
- 5.5%
- Beta (default)
- 1.00
- Cost of equity
- 8.5%
- Terminal growth
- 2.0%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 45.8% of at least 60%
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | 13.0% | 81 (vs peers) | 14% |
| FCF conversion · Quality | 78.3% | 69 (on a fixed band) | 14% |
| Revenue CAGR 3Y · Growth | unavailable | unavailable | — |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | unavailable | unavailable | — |
| Current ratio · Balance sheet | 2.6x | 100 (on a fixed band) | 9% |
| P/E (TTM) · Valuation | 19.3x | 64 (vs peers) | 23% |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | 4.1% | 51 (on a fixed band) | 18% |
| Shareholder yield (distributions) · Returns | 3.6% | 52 (on a fixed band) | 14% |
| Payout ratio (FCF) · Returns | 89.3% | 44 (on a fixed band) | 9% |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet· partial100/100 · 1/3 factors with a value
- Growth· partialunavailable · 0/2 factors with a value
- Quality75/100 · 2/3 factors with a value
- Returns49/100 · 2/2 factors with a value
- Valuation58/100 · 2/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
FAES FARMA SA (FAE.MC). Latest full fiscal year: 2025; data up to 2025-12-31.
Figures computed from the financial statements: revenue 610.5 m EUR in 2025; YoY growth 23.7%; net margin 13.0%; ROE 10.8%.
The estimated value range is 3.15–4.55 EUR per share (median of 2 methods, agreement: low); assumptions are illustrative. Against the central value of 3.98 EUR, the price of 4.91 EUR leaves a potential of -19.0% (value / price − 1) and a margin of safety of -23.4% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
Insufficient data for a verdict (score weight coverage: 45.8% of at least 60%).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Net margin: 13.0%
- Current ratio: 2.6x
What contradicts it
- The price is above the estimated value range
- The valuation methods diverge
Not assessed (insufficient data or a ratio without meaning): ROIC, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, Interest coverage, EV/EBITDA.
Versus the vertical median
Listed companies from Spain · same country · compared with 39 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| ELE.MCEndesa SA | 46.9 bn | 21.4 | 26.4% | 10.5% | +0.5% | +43% / +134% |
| AENA.MCAena S.m.e. SA | 42.6 bn | 19.9 | 24.2% | 34.0% | +8.9% | +21% / +79% |
| AMS.MCAmadeus It Group Sociedad Anonima | 26.2 bn | 19.8 | 26.9% | 20.5% | +6.1% | −6% / −5% |
| ACS.MCAcs Actividades De Construccion Y Servicios, S.A. | 21.9 bn | 23.0 | 19.9% | 1.9% | +19.7% | +7% / +134% |
| ANA.MCAcciona SA | 11.7 bn | 14.5 | 16.9% | 4.0% | +5.5% | +24% / +66% |
| FCC.MCFomento De Construcciones Y Contratas S.A. | 5.0 bn | 30.3 | 5.3% | 1.7% | +6.9% | −8% / −14% |
| FDR.MCFluidra S.A. | 3.8 bn | 21.3 | 10.9% | 7.8% | +4.1% | −17% / +4% |
| DIA.MCDistribuidora Internacional De Alimentacion SA | 2.7 bn | 20.6 | 165.6% | 2.2% | −2.7% | +51% / +380,733% |
| CMO.MCCementos Molins S.A. | 2.5 bn | 13.6 | 14.3% | 18.0% | −3.1% | +31% / unavailable |
| ENO.MCElecnor SA | 2.4 bn | 21.9 | 10.5% | 2.5% | +15.1% | −3% / +58% |
| ALM.MCAlmirall S.A. | 2.4 bn | 51.1 | 3.1% | 4.2% | +12.4% | −11% / +32% |
| FAE.MCFaes Farma SA | 1.5 bn | 19.3 | 10.8% | 13.0% | +23.7% | +3% / +57% |
| AEDAS.MCAedas Homes SA | 1.0 bn | 17.1 | 57.8% | 7.0% | −24.8% | +0% / +38% |
| EDR.MCEdreams Odigeo SA | 574.4 m | 11.5 | 21.0% | 7.8% | −0.4% | +40% / −24% |
| EAT.MCAmRest Holdings SE | 506.0 m | 31.4 | 4.3% | 0.6% | +0.1% | −34% / −61% |
| ADX.MCAudax Renovables S.A. | 468.5 m | 23.9 | 9.3% | 1.0% | −5.4% | −23% / −18% |
| ATRY.MCAtrys Health, S.A. | 200.4 m | — | -49.5% | -71.1% | +8.5% | −3% / −29% |
| ENER.MCEcoener, S.A. | 175.6 m | 32.2 | 4.2% | 6.4% | +3.6% | −34% / −6% |
| ADZ.MCAdolfo Dominguez SA | 62.9 m | 38.3 | 9.0% | 1.2% | +1.8% | +39% / +40% |
| DESA.MCDesarrollos Especiales De Sistemas De Anclaje S.A. | 44.8 m | 9.2 | 152.3% | 10.0% | +2.2% | +19% / unavailable |
| EZE.MCGrupo Ezentis SA | 29.0 m | — | — | -9.3% | +147.2% | −30% / −37% |
| CLEO.MCCompañia Levantina De Edificacion Y Obras Publicas SA | 17.3 m | 14.4 | 4.1% | 3.4% | +13.4% | unavailable / unavailable |
| AYC.MCAyco Grupo Inmobiliario, S.A. | 16.4 m | — | -33.8% | — | −100.0% | unavailable / unavailable |
| EBRO.MCEbro Foods, S.A. | 3.0 m | 0.0 | 10.0% | 7.7% | −4.0% | −0% / +19% |
| A3M.MCAtresmedia Corporacion De Medios De Comunicacion, S.A. | — | — | 7.9% | 6.9% | −2.7% | +13% / +60% |
1- and 3-year price returns: for FAE.MC from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (EUR)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 3.23 Total return -31% · Per year -31% | 5.69 Total return 20% · Per year 20% | 8.54 Total return 79% · Per year 79% |
| 3 years | 3.84 Total return -11% · Per year -4% | 7.53 Total return 68% · Per year 19% | 12.29 Total return 169% · Per year 39% |
| 5 years | 4.55 Total return 12% · Per year 2% | 9.95 Total return 131% · Per year 18% | 17.70 Total return 298% · Per year 32% |
- Exit P/E± 1.88
- Net margin± 1.32
- Annual revenue growth± 0.98
- Annual dilution± 0.11
AI analysis
The qualitative analysis has not been written for this company yet.
Products, market & competition
The qualitative analysis has not been written for this company yet.
News & filings
In the press
No news in our archive over the last 180 days.
Annual reports (ESEF)
- Annual report 202520 Oct 2026
- Annual report 202520 Oct 2026
- Annual report 202408 May 2025
- Annual report 202408 May 2025
Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.